SynthesisPloS one2022

The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.

Christopher Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.